These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers. Zhang Y; Yao X; Zhou H; Wu X; Tian J; Zeng J; Yan L; Duan C; Liu H; Li H; Chen K; Hu Z; Ye Z; Xu H Nucleic Acids Res; 2022 Jan; 50(D1):D1340-D1347. PubMed ID: 34554251 [TBL] [Abstract][Full Text] [Related]
4. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases. Mercatante DR; Sazani P; Kole R Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880 [TBL] [Abstract][Full Text] [Related]
5. Alternative Splicing as a Target for Cancer Treatment. Martinez-Montiel N; Rosas-Murrieta NH; Anaya Ruiz M; Monjaraz-Guzman E; Martinez-Contreras R Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439487 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of splicing in cancer. Lee SC; Abdel-Wahab O Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment. Lin JC Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283381 [TBL] [Abstract][Full Text] [Related]
8. [Perspectives of RNA interference application in the therapy of diseases associated with defects in alternative RNA splicing]. Wysokiński D; Błasiak J Postepy Hig Med Dosw (Online); 2012 Sep; 66():683-95. PubMed ID: 23001210 [TBL] [Abstract][Full Text] [Related]
9. The role of alternative splicing in cancer: From oncogenesis to drug resistance. Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093 [TBL] [Abstract][Full Text] [Related]
10. Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy. Mehterov N; Kazakova M; Sbirkov Y; Vladimirov B; Belev N; Yaneva G; Todorova K; Hayrabedyan S; Sarafian V Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356101 [TBL] [Abstract][Full Text] [Related]
11. Modification of alternative splicing pathways as a potential approach to chemotherapy. Mercatante D; Kole R Pharmacol Ther; 2000 Mar; 85(3):237-43. PubMed ID: 10739878 [TBL] [Abstract][Full Text] [Related]
12. ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers. Wu S; Huang Y; Zhang M; Gong Z; Wang G; Zheng X; Zong W; Zhao W; Xing P; Li R; Liu Z; Bao Y Nucleic Acids Res; 2023 Jan; 51(D1):D1196-D1204. PubMed ID: 36318242 [TBL] [Abstract][Full Text] [Related]
13. Alternative splicing: an emerging topic in molecular and clinical oncology. Pajares MJ; Ezponda T; Catena R; Calvo A; Pio R; Montuenga LM Lancet Oncol; 2007 Apr; 8(4):349-57. PubMed ID: 17395108 [TBL] [Abstract][Full Text] [Related]
14. Alternative splicing in cancers: From aberrant regulation to new therapeutics. Song X; Zeng Z; Wei H; Wang Z Semin Cell Dev Biol; 2018 Mar; 75():13-22. PubMed ID: 28919308 [TBL] [Abstract][Full Text] [Related]